SEC Company Response from Viskase Holdings, (VISK) — Sep 17, 2020

Viskase Holdings, Inc.
Date: Sept. 17, 2020 · CIK: 0000727510 · Accession: 0001104659-20-106072

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-248528

Date

September 17, 2020

Author

Form

CORRESP

Company

Viskase Holdings, Inc.

Letter

VIA EDGAR SUBMISSION Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Registration Statement on Form S-1 (File No. 333-248528) (the “Registration Statement”)

Re: Enzon Pharmaceuticals, Inc. (the “Company”)

Dear Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on Monday, September 21, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.

If you have any questions regarding this request, please contact our outside counsel, Todd Mason of Thompson Hine LLP, at (212) 908-3946. Please also call Todd Mason as soon as the Company’s Registration Statement on Form S-1 has been declared effective. Thank you for your attention to this matter.

Sincerely,
ENZON PHARMACEUTICALS, INC.

Show Raw Text

CORRESP
1
filename1.htm

September 17, 2020

VIA EDGAR SUBMISSION

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 Re: Enzon Pharmaceuticals, Inc. (the “Company”)

Registration Statement on Form S-1 (File No. 333-248528)
(the “Registration Statement”)

Dear Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities
Act of 1933, as amended (the “Securities Act”), the Company hereby requests that the Securities and Exchange Commission
(the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become
effective on Monday, September 21, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.

If you have any questions regarding this request, please contact
our outside counsel, Todd Mason of Thompson Hine LLP, at (212) 908-3946. Please also call Todd Mason as soon as the Company’s
Registration Statement on Form S-1 has been declared effective. Thank you for your attention to this matter.

    Sincerely,

    ENZON PHARMACEUTICALS, INC.

    By:
    /s/ Andrew Rackear

    Name:
    Andrew Rackear

    Title:
    Chief Executive Officer and Secretary

 cc: Todd E. Mason, Thompson Hine LLP

SecProbe.io